Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance
<p>REHOVOT, Israel, Sept. 30, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) (the "Company", "Evogene"), a pioneer in computational chemistry specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, today reported that the...</p>
Read original article ↗
Related Articles
AudioEye Study Finds AI Coding Tools Do Not Write Accessible Code
81% of developers trust AI-generated code for accessibility, but the data shows they should not TUCSON, Ariz., Sept. 30,
The new ticker will begin trading on September 30, 2026 No action is required from current shareholders; ticker conversi
In this free webinar, learn how clinical development teams can build the governance, data and operational foundations ne
Three-year agreement marks QSSN's first recurring commercial deployment, with LINE NEXT's Unifi Wallet among the first c